About Pisit “Duke” Pitukcheewanont, MD, FAAP:
Dr. Pisit “Duke” Pitukcheewanont is Lumos Pharma’s Chief Medical Officer. A seasoned pediatric endocrinologist with over 25 years of combined clinical expertise and research contributions in the field, he currently serves as Adjunct Professor of Clinical Pediatrics at the Children’s Hospital of Los Angeles, Keck School of Medicine of the University of Southern California, and has been a faculty physician there since 1998. Concurrently, he also serves as the President of the Human Growth Foundation, a global non-profit committed to advancing research, delivering education, and championing support for endocrinologists, healthcare practitioners, as well as individuals and families impacted by growth disorders. Throughout his career, Dr. Pitukcheewanont has been the recipient of numerous research grants and has authored over 70 publications.
Dr. Pitukcheewanont initially joined Lumos Pharma in May 2022 as Vice President of Global Clinical Development and Medical Affairs. His role expanded in June 2023 when he assumed the position of Senior Vice President in the same capacity.
Before joining Lumos Pharma, Dr. Pitukcheewanont served in key roles as the Vice President of Medical Affairs and Vice President of Global Medical Ambassador and Medical Education at Ascendis Pharma. During this time, he was instrumental in spearheading the development and pre-launch medical strategies for Skytrofa®, the weekly injectable growth hormone designed for PGHD (Pediatric Growth Hormone Deficiency). Furthermore, Dr. Pitukcheewanont has maintained an active engagement with several pharmaceutical and rare disease companies, contributing his expertise by serving on numerous advisory and executive boards.
Dr Pitukcheewanont received his MD from Chiang Mai University in Thailand as well as completing his pediatric residency. He also completed an internship, residency and fellowship in diabetes, endocrinology & metabolism at University of Tennessee, at both their Memphis and Knoxville campuses.